Document Detail

Acute kidney injury in critically ill cirrhotic patients: a review.
MedLine Citation:
PMID:  22481447     Owner:  NLM     Status:  MEDLINE    
Acute kidney injury (AKI) is an important marker of morbidity and mortality in critically ill cirrhotic patients. The most common causes of AKI in cirrhotic patients include prerenal or hepatorenal syndrome (HRS). Diagnosis of AKI may be delayed by the lack of clinical, biochemical, and radiological markers with proven sensitivity and specificity in cirrhotic patients. In this review, we discuss the epidemiology, pathophysiology, diagnosis, and therapies for AKI in cirrhotic patients admitted to an intensive care unit (ICU).
Jimena Muciño-Bermejo; Raúl Carrillo-Esper; Misael Uribe; Nahum Méndez-Sánchez
Related Documents :
9049117 - Diagnostic and cost effectiveness of telemonitoring the pediatric pacemaker patient.
687477 - Long-term oral antiarrhythmic therapy with mexiletine.
22348347 - Severe acute respiratory failure secondary to acute fibrinous and organizing pneumonia ...
24934617 - Childhood maltreatment, adult attachment and psychotic symptomatology: a study in patie...
21760637 - Patients' preferred terms for describing their excess weight: discussing obesity in cli...
8486037 - Differential lobe lavage for diagnosis of acute pneumocystis carinii pneumonia in patie...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Annals of hepatology     Volume:  11     ISSN:  1665-2681     ISO Abbreviation:  Ann Hepatol     Publication Date:    2012 May-Jun
Date Detail:
Created Date:  2012-04-06     Completed Date:  2012-08-23     Revised Date:  2013-05-16    
Medline Journal Info:
Nlm Unique ID:  101155885     Medline TA:  Ann Hepatol     Country:  Mexico    
Other Details:
Languages:  eng     Pagination:  301-10     Citation Subset:  IM    
Intensive Care Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Kidney Injury / diagnosis,  epidemiology*,  physiopathology*
Biological Markers / blood
Critical Illness / epidemiology*
Cystatin C / blood
Kidney / ultrasonography
Liver Cirrhosis / epidemiology*,  physiopathology
Renal Replacement Therapy
Vasoconstrictor Agents / therapeutic use
Reg. No./Substance:
0/Biological Markers; 0/Cystatin C; 0/Vasoconstrictor Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment of hyperferritinemia.
Next Document:  Different models in predicting the short-term prognosis of patients with hepatitis B virus-related a...